Patents by Inventor John R. Didsbury

John R. Didsbury has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180153860
    Abstract: The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders.
    Type: Application
    Filed: December 2, 2016
    Publication date: June 7, 2018
    Applicant: T3D Therapeutics, Inc.
    Inventor: John R. Didsbury
  • Publication number: 20180153859
    Abstract: The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders based on the ApoE4 genotype of human subjects.
    Type: Application
    Filed: December 2, 2016
    Publication date: June 7, 2018
    Applicant: T3D Therapeutics, Inc.
    Inventor: John R. Didsbury
  • Patent number: 9248098
    Abstract: The present invention relates to a pharmaceutical composition comprising spicamycin derivatives that vary in their fatty acid side chain moieties and are useful in the treatment of pain. The invention further provides a method of using the pharmaceutical composition to treat pain, including neuropathic pain.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: February 2, 2016
    Assignee: DARA BIOSCIENCES, INC.
    Inventors: John R. Didsbury, Kenneth J. Ingold, Linda Goff Jet, Andrew Xian Chen, Hailiang Chen
  • Publication number: 20110237536
    Abstract: The present invention relates to the use of spicamycin derivatives for treatment and/or prevention of pain, including neuropathic pain. The invention further relates to pharmaceutical compositions of spicamycin derivatives suitable for treatment or prevention of pain.
    Type: Application
    Filed: October 9, 2009
    Publication date: September 29, 2011
    Inventors: John R. Didsbury, Kenneth J. Ingold, Linda Goff Jet, Andrew Xian Chen, Hailiang Chen
  • Publication number: 20100210695
    Abstract: The present invention is directed to pharmaceutical compositions formulated for topical administration comprising an inhibitor of carnitine palmitoyl transferase (CPT1) and methods for treating skin disorders, such as psoriasis, by administration of a CPT1 inhibitor. In particular embodiments, the invention provides a pharmaceutical composition formulated for topical administration comprising the CPT1 inhibitor ST1326. In other embodiments, the invention provides a method of treating a skin disorder, such as psoriasis by administration of the CPT1 inhibitor ST1326.
    Type: Application
    Filed: June 19, 2008
    Publication date: August 19, 2010
    Applicant: DARA BIOSCIENCES, INC.
    Inventor: John R. Didsbury
  • Publication number: 20090264384
    Abstract: Benzimidazole, indole and benzolactam boronic acid compounds, analogs thereof, and pharmaceutical formulations are described, along with methods of use thereof for inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-?) in a subject in need thereof.
    Type: Application
    Filed: November 10, 2008
    Publication date: October 22, 2009
    Applicant: Nuada, Inc.
    Inventors: John R. Didsbury, Tatyana Dyakonov, Simon N. Haydar, Michael L. Jones, Francine F. Li, Christopher J. Markworth, Jessy Matthew, Frank J. Schoenen, Jan J. Scicinski, David Middlemiss, James F. Burns, Leonard A. Cabana, Glenn C. Collupy, David N. Vanvliet
  • Publication number: 20090005344
    Abstract: Imidazole and benzimidazole boronic acid compounds, analogs thereof, and pharmaceutical formulations are described, along with methods of use thereof for inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-?) in a subject in need thereof.
    Type: Application
    Filed: October 27, 2005
    Publication date: January 1, 2009
    Applicant: NKUADA, LLC
    Inventors: James F. Burns, Leonardo A. Cabana, Glenn C. Collupy, John R. Didsbury, Tatyana A. Dyakonov, Simon N. Haydar, Michael L. Jones, Francine F. Li, Christopher J. Markworth, Jessymol Mathew, Frank J. Schoenen, David S. Van Vliet, David Middlemiss
  • Publication number: 20080319044
    Abstract: Indole boronic acid compounds, and analogs thereof, and pharmaceutical formulations are described, along with methods of use thereof for inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-?) in a subject in need thereof.
    Type: Application
    Filed: October 27, 2005
    Publication date: December 25, 2008
    Applicant: NUADA, LLC
    Inventors: John R. Didsbury, Tatyana A. Dyakonov, Simon N. Haydar, Michael L. Jones, Francine F. Li, Christopher J. Markworth, Jessymol Mathew, Frank J. Schoenen, Jan J. Scicinski, David Middlemiss